Is consolidative thoracic radiotherapy of extensive-stage small cell lung cancer still beneficial in the era of immunotherapy? A retrospective analysis

PURPOSE: Extensive-stage small cell lung cancer (ES-SCLC) carries a dismal prognosis. The benefit of consolidative thoracic radiotherapy (TR) after first-line chemoimmunotherapy with PD-L1 inhibitors in this setting remains unclear. As TR can improve overall survival (OS) after conventional chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Elgin, De-Colle, Chiara, Potkrajcic, Vlatko, Baumann, David, Spengler, Werner, Gani, Cihan, Utz, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281891/
https://www.ncbi.nlm.nih.gov/pubmed/37039832
http://dx.doi.org/10.1007/s00066-023-02075-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281891/
https://www.ncbi.nlm.nih.gov/pubmed/37039832
http://dx.doi.org/10.1007/s00066-023-02075-9

Ejemplares similares